SPY Archives - Page 171 of 182 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Cannabis News Play & More

Stereo Vision Entertainment SVSN

We had SVSN hit our scanner this morning after we noticed an interesting PR coming across the wires. We’re always looking for new interests in the cannabis space, and SVSN fits that bill. Unlike many of the companies in the business conduct their activities primarily in the western states, SVSN has an operation in Florida.

The company just announced a February 1, 2018 Grand Opening of its majority owned subsidiary CannaVision’s Bay Pines medical cannabis and holistic pain management clinic in St Petersburg, Florida. (>>View PR)

We’ll be interested to track the progress of this new facility, and SVSN stock itself going forward.

SPDR S&P 500 ETF (SPY)

We also want to throw in a quick options idea for the SPY, which despite a momentary hiccup in its week’s-long bullish trend yesterday, looks to be gapping up and ready to get back on track today. There are a set of contracts expiring today that we want to radar: the SPY 01/17 $277.50-279 Calls*.

Please be aware that contracts approaching expiration are subject to evaporating premiums due to time decay, so these are quick-strike opportunities only. We’ll be looking for the classic early dip and rip pattern, which should present those chances for intraday flips.

*Be aware that this idea is extremely high risk, and for advanced level traders only!

Extended Watchlist:
TVPC, DDD, MITK, ADAP, ARGS, IOVA

Blue Horseshoe Stocks: CAPR Recap & More

Capricor Therapeutics, Inc. CAPR

We included CAPR in yesterday’s premarket watchlist after noticing some abnormal volume and price action in the stock during the previous session. Prior to that it had been trading sideways for more than a month.

It turns out our alert came just in the nick of time, because yesterday CAPR exploded for its largest single-session spike in years. The stock opened at 1.50 and managed to run as high as 2.65, filling a good portion of the large gap on its chart, left in May. It came out to an intraday push of 77% which came on monstrous volume of just under 80 times the monthly average.

SPDR S&P500 ETF (SPY)

We discussed tracking the SPY Weekly $249.50 & $250 Calls as conditions appeared favorable to another bullish day for the market in general. The fund made a pretty solid move during the session, and that produced some decent opportunities in our designated contracts.

The $249.50’s traded from .55 to a high of .83 (+51%), while the $250’s did slightly better with a run from .29 to .49 (+69%) just before lunch hour.

Helios and Matheson Analytics, Inc. HMNY

We last tagged HMNY on August 15th, and after a solid run, the stock went under consolidation for a few weeks. However, the downturn ended at the end of last week and the move it’s made since has been pretty impressive.

HMNY saw a low of 2.42 on Thursday, and yesterday the stock achieved a new high of 6.40. That represents a four -session upswing of 164% while volume over the same period has been significantly increased.

HTG Molecular Diagnostics, Inc. HTGM

We’re interested to track HTGM today after the company announced the issuance of two method patents on its technology. We’re seeing a moderate gap-up in the premarket, but there still appears to be the good chance for a solid upside here. The stock does have a recent history containing a huge spike to more than $12.

We’ll place it on watch, and look for it to establish a string of sessions recording higher highs and higher lows moving forward.

Extended Watchlist:
WAC, DMPI, KPTI, SPI, ARWR, ALRT, PZRX, CEI

Blue Horseshoe Stocks: DMTX Review, Options & More

Dimension Therapeutics, Inc. DMTX

We alerted on DMTX after a sizable gap-up few weeks back on the morning of August 25th. That day we would observe a low of 2.90 in the stock, and it never looked back.

Throughout the month of September the stock has mostly been stair-stepping its way up in steady fashion, but news of an unsolicited buyout offer (@5.50/share) kicked this play into a much higher gear to start things off this week, and yesterday DMTX attained a high of 5.90.

That works out to a three-week double-bag swing of 103% We wouldn’t expect to see the stock travel much higher, certainly not without confirmation or further details on a proposal, but will still keep our eyes open for further activity after a very strong session yesterday.

Fresh Options Ideas

We’ve got a pair of options possibilities to present this morning. Yesterday’s market sentiment was exceedingly bullish, with more than 65% of NASDAQ quoted stocks trading at or above their 50-day moving averages.

Today, better than expected numbers on Housing Starts and Building Permits were reported, which could assist in keeping the momentum moving.

SPDR S&P500 ETF (SPY) – For a direct market analog, we generally turn to the SPY, having had immense success with it on several separate occasions in the past. We’re going to signal the SPY Weekly $249.50 & $250 Calls for observation as we approach midweek.
_____

The Kroger Co. KR – We’re also noticing a heck of a bottom setup on KR. A strong multiple bottom signal showing the stock at a solid support level, and a couple of gaps to the upside on the chart leaves us looking at a pair of longer-term contracts. We’re going to place the KR 11/17 $23 & $24 Calls on watch in the event of a recovery for Kroger.

Extended Watchlist:
STAF, CAPR, MRTX, NTEC, NBRV, RNVA, AGTC

Blue Horseshoe Stocks: TTOO Recap & More

T2 Biosystems, Inc. TTOO – Recap

We tagged TTOO as a bottom play just under a month ago in our report dated July 18th, as the stock was undergoing a lengthy period of consolidation. It subsequently found support at 2.53 shortly thereafter, and since that point in time, it has seen a solid recovery off of those lows.

Yesterday, TTOO reached a new high of 4.07, its best PPS all summer long. It worked out to a very respectable 61% upswing over our observed low, and indicators on the chart suggest there is still room for more rapid short term growth, so we’ll continue to keep an eye on this play moving forward.

SPDR S&P 500 ETF Trust (SPY) – Options Update

The markets ended up rebounding yesterday, leading us to note our interest in tracking the SPY Weekly $244.50-246 Calls in the event that the premarket trend we were noticing continued into the session. That’s what happened, and as a result our highlighted contracts made some really nice intraday moves.

$244.50 Calls – Range: 1.54-2.53 – Max Gain: 1180%
$245 Calls – Range: 1.18-2.05 – Max Gain: 1280%
$245.50 Calls – Range: .83-1.68 – Max Gain: 1225%
$246 Calls – Range: .54-1.30 – Max Gain: 1864%

The possibility of a sustained rally for the markets will lead us to roll up our potential strike prices in the SPY chain up to the $247 and $247.50 Calls to potentially keep this idea rolling.

Zerez Holdings Corp. ZRZH

We first caught wind of ZRZH last year, and it was good to us back then. We want to revisit the stock once again today for a couple reasons.

Not only is ZRZH in a relatively good place on the chart from which to launch a possible rebound, but yesterday the company presented some impressive quarter-over-quarter revenue growth. For those reasons, we want to place this stock on watch this week, a rebound to its previous area of fierce resistance at a nickel would mean considerable gain opportunities from present pricing.

SACRAMENTO, Calif., Aug. 14, 2017 /PRNewswire/ — Zerez Holdings Corporation, (OTC PINK: ZRZH), DBA Smart Cannabis, http://smartcannabis.com today filed its second quarter 2017 quarterly reports with OTCMARKETS. The company reported $2,041,557 in gross revenue, about a 275% increase over first quarter revenues of $544,467 (>>View Full PR)

Extended Watchlist:
AMRS, HMNY, EXTR, DSLV, IDXG, FRSX, FPP

Blue Horseshoe Stocks: Bottom Play, Options & More

Biocept, Inc. BIOC

We took notice of BIOC on our routine morning scan today as a possible bottom play, as the stock tumbled to 8-month lows on Friday. At the same time, the company released a PR this morning pertaining to the signing of a potentially lucrative, worldwide distribution agreement, a snippet of which we’ve included below.

We think it makes for an interesting confluence of events, and that’s why we’re going to be tracking BIOC closely as we kick off a fresh trading week.

SAN DIEGO, Aug. 14, 2017 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has signed an exclusive global Distribution Agreement excluding China, for the Company’s proprietary blood collection tubes (BCTs) with VWR International, LLC (>>View Full PR)

National and International Events Affecting Markets

There was a fair bit of hysteria going out over the newsreels last week over a potential nuclear conflict between North Korea and the US, and it led to a tough week for stocks in general. Whether this week plays out as a bear or a bull remains to be seen, but we’ll want to have options ideas lined up for either eventuality.

This morning, we’ve seen some signs of an abatement of those fears as stocks around the globe have perked up, and in the event that a rebound for domestic stocks is also in the cards for this week, we’ll want to signal the range of SPDR S&P 500 ETF Trust (SPY) Weekly $244.50-246 Calls for observation.

However if other outside factors, such as the civil unrest and domestic terrorism that unfolded in Virginia over the weekend serves to hurt US markets further, we may find ourselves more interested in tracking the iPath S&P 500 VIX ST Futures ETN (VXX) Weekly $12 and 12.50 Calls.

Extended Watchlist:
ZSAN, FCAU, CLMT,CVM CERC, FRSX